Biopol Chemicals IPO allotment status: The basis of allotment of shares for the initial public offering (IPO) of speciality chemicals manufacturer Biopol Chemicals is expected to be finalised today, Wednesday, February 11, 2026. The maiden public issue closed for subscription on Tuesday, February 10, 2026, receiving a solid response from investors.
Biopol Chemicals IPO received an overall subscription of 22.33 times, with bids for 61.26 million shares against 2.74 million shares on offer. The portion reserved for Non-institutional investors (NIIs) was booked over 24.49 times, followed by the qualified institutional buyers (QIBs) quota at 21.05 times, and the retail investors’ portion was booked 21 times.
Here’s how to check Biopol Chemicals IPO allotment status:
Once the allotment is finalised, investors can check their allotment status from the official websites of the National Stock Exchange (NSE) and the registrar, Bigshare Services. Alternatively, investors can use the following links to check Biopol Chemicals’ IPO allotment status directly:
Biopol Chemicals IPO GMP
According to sources tracking unofficial market activity, the company’s shares were trading at around ₹112 apiece, commanding a premium of ₹4 or 3.7 per cent on Wednesday. However, these estimates may vary, as the grey market is unregulated and GMP should not be considered a reliable indicator of actual market performance.
Biopol Chemicals IPO details
The ₹31.26-crore IPO of Biopol Chemicals comprised a fresh issue of 2.9 million equity shares, and no offer-for-sale (OFS) component.
The IPO was offered in a price band of ₹102–108 per share with a lot size of 1,200 shares. The issue was open for subscription from Friday, February 6, to Tuesday, February 10, 2026.
Shares of Biopol Chemicals are scheduled to list on the NSE SME platform on Friday, February 13, 2026.
As per the red herring prospectus (RHP), the company plans to utilise ₹12.26 crore from the net fresh issue for the acquisition of industrial land, and ₹11.10 crore for repayment or prepayment of certain borrowings. The remaining funds will be used for general corporate purposes.